Medicine Purchases / US Tariffs Deadline
By Fernando Mares | Journalist & Industry Analyst -
Tue, 04/01/2025 - 14:02
Medicine Purchases. Eduardo Clark, Deputy Minister of Integration and Development of the Health Sector reported on the progress of medicine and health supply procurement and distribution, stating that 381 million units were requested in March 2025, representing 1.8 months of supply. Of that request, 233 million units, 61% of the total, have already been received.
IMSS Hospital Construction Projects. Zoé Robledo, Director, IMSS, reported that the government invested MX$7.5 billion (US$368 million) in hospital infrastructure rehabilitation in 2024. Robledo announced that MX$7.45 billion will be invested in 2025 for maintenance, infrastructure, and equipment across eight programs and 1,990 strategic projects.
These programs include the intervention of 82 Emergency and Continuous Medical Care Areas, for which MX$497 million are allocated; the intervention of 24 hospitals in 16 states, with an investment of MX$1.8 billion; the intervention of 124 Intensive Care Units in 25 states, with MX$1.7 billion; the intervention of 908 areas in medical residencies, receiving MX$1.4 billion; the intervention of 107 internal hemodialysis areas, with MX$734 million; 551 accessibility works, allocated MX$323 million; the intervention of 137 Mental Health Care Areas, with MX$176 million; and the intervention of 54 sub-delegation properties, for which MX$669 million are designated.
US Tariffs Deadline. President Sheinbaum stated that Mexico will respond on April 3, 2024, to tariffs imposed by US President Donald Trump. She emphasized ongoing dialogue and referred to Plan México as the nation's strategy for strengthening its economy in response to tariff threats.
She also reiterated that Mexico would wait for the final decision regarding tariffs, considering the close integration of certain industries with the United States. Sheinbaum added that the rules of origin under the USMCA trade agreement are more advantageous for Mexico than relying on the WTO’s most favored nation status.









